Colin Lindsay
Christie NHS Foundation Trust, University of Manchester, Manchester, UK
Dr Lindsay is a Clinical Senior Lecturer in medical oncology, working at the University of Manchester and the Christie NHS Foundation Trust to divide his time 50/50 between research and the clinic. He trained at the CRUK Beatson Institute and Cancer Centre in Glasgow, where he completed a PhD under Owen Sansom studying genetically-modified mouse models of RAS- and RAF-driven melanoma. Following that he shifted focus to lung cancer translation through involvement with the CRUK Stratified Medicine Programme, as well as a two year ESMO translational fellowship with Benjamin Besse and Jean-Charles Soria at the Gustave Roussy Institute in Villejuif, France. His main research interests are 1) the implementation of effective treatment strategies for cancers driven by the MAPK pathway, and 2) successful and efficient translation of genomic results for optimal clinical gain.
Dr Lindsay is a Clinical Senior Lecturer in medical oncology, working at the University of Manchester and the Christie NHS Foundation Trust to divide his time 50/50 between research and the clinic. He trained at the CRUK Beatson Institute and Cancer Centre in Glasgow, where he completed a PhD under Owen Sansom studying genetically-modified mouse models of RAS- and RAF-driven melanoma. Following that he shifted focus to lung cancer translation through involvement with the CRUK Stratified Medicine Programme, as well as a two year ESMO translational fellowship with Benjamin Besse and Jean-Charles Soria at the Gustave Roussy Institute in Villejuif, France. His main research interests are 1) the implementation of effective treatment strategies for cancers driven by the MAPK pathway, and 2) successful and efficient translation of genomic results for optimal clinical gain.
